Scribe Therapeutics, Inc. ($SCTX)
Filing Information
| Accession Number | 0000947871-26-000734 |
|---|---|
| Form Type | 4 |
| Filing Date | Jul 29, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
3,414,497
Total Value
$15,000,000.00
P&L
+22.4% (+$3,360,000.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Jul 27, 2026 | Conversion | 348,825 | โ | โ | 348,825 | Indirect | See footnotes | View Details | |
Director | Common Stock | โ | Jul 27, 2026 | Purchase | 1,000,000 | $15.00 | $15,000,000.00 | 1,348,825 | Indirect | See footnotes | View Details | |
Director | Series B Preferred Stock | Derivative | Jul 27, 2026 | Conversion | 2,065,672 | $0.00 | $0.00 | 0 | Indirect | See footnotes | View Details |